Join session

Evaluation of AI Technologies & EU HTA: Towards European Standards?

Nov 21, 2024 — 05:10 pm CET - 5:35 PM CET

Presented by

Policy Analyst - Data, AI & Health

Norwegian Centre for E-health Research

Director of Communications

Jérôme Fabiano

EIT Health France

Deputy Managing Director

Presented by

Charlotte Barot

AI Analyst

RDB

Rossella Di Bidino

HTA and AI expert

Jérôme Fabiano

Deputy Managing Director

Randi Laukli

Director of Communications

DDŞ

Dr. Derya Şahin

Policy Analyst - Data, AI & Health

In partnership with

Suggested sessions

Nov 21st

9:10 am - 9:20 am

Artificial Intelligence: On a Mission to Make Drug Development Faster and Smarter

Discover how AI is transforming the pharmaceutical industry and its impacts on the future of innovation. Through concrete used cases, this session will specifically...

Reda Guiha

Pfizer

Country President France

Damien Gromier

AI for Health by Artefact

CEO & Founder

Join session

Evaluation of AI Technologies & EU HTA: Towards European Standards?

Nov 21, 2024 — 05:10 pm CET - 5:35 PM CET

Presented by

Charlotte Barot

AI Analyst

Rossella Di Bidino

HTA and AI expert

Jérôme Fabiano

Deputy Managing Director

Randi Laukli

Director of Communications

Dr. Derya Şahin

Policy Analyst - Data, AI & Health

The Day at a Glance and our Vision for 2025

Leaders' POV: Accelerating Drug Innovation Through AI at Servier

Towards a Patient Outcome-Based System: The Promise of Value-Based Healthcare

Artificial Intelligence: On a Mission to Make Drug Development Faster and Smarter

Subscribe to our Newsletter